Skip to main content
Veterinary Medicines

ZODON 88 MG CHEWABLE TABLETS FOR DOGS

Authorised
  • Clindamycin hydrochloride

Product identification

Medicine name:
ZODON 88 MG CHEWABLE TABLETS FOR DOGS
Givix Vet. 88 mg tyggetabletter
Active substance:
  • Clindamycin hydrochloride
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Clindamycin hydrochloride
    95.57
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Chewable tablet
Withdrawal period by route of administration:
  • Oral use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01FF01
Authorisation status:
  • Valid
Authorised in:
  • Denmark
Package description:
  • Cardboard box of 20 tablets containing 2 blisters of 10 tablets
  • Cardboard box of 100 tablets containing 10 blisters of 10 tablets
  • Cardboard box of 120 tablets containing 12 blisters of 10 tablets
  • Cardboard box of 240 tablets containing 24 blisters of 10 tablets
  • Cardboard box of 10 tablets containing 1 blister of 10 tablets

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Ceva Sante Animale
Marketing authorisation date:
Manufacturing sites for batch release:
  • Ceva Sante Animale
Responsible authority:
  • Danish Medicines Agency
Authorisation number:
  • 52714
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0362/003
Concerned member states:
  • Austria
  • Belgium
  • Czechia
  • Denmark
  • Finland
  • Germany
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Luxembourg
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Danish (, TYGGETABLETTER 88 MG)
Published on: 29/06/2023
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."